Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinoma

2015 ◽  
Vol 33 (3) ◽  
pp. 113.e1-113.e7 ◽  
Author(s):  
Daniele Minardi ◽  
Matteo Santoni ◽  
Guendalina Lucarini ◽  
Roberta Mazzucchelli ◽  
Luciano Burattini ◽  
...  
2017 ◽  
Vol 19 (2) ◽  
pp. 207-212 ◽  
Author(s):  
Enjing Chen ◽  
Fufu Zheng ◽  
Xiaoxu Yuan ◽  
Yunlin Ye ◽  
Xiaofei Li ◽  
...  

2018 ◽  
Vol 54 (2) ◽  
pp. 102
Author(s):  
Yohana Octavianda ◽  
Anny Setijo Rahaju

There is an increase in renal cell carcinoma in males aged over fifty years with smoking risk factors. Clear cell renal cell carcinoma is the most common malignant tumor found in the kidneys that have an aggressive nature. This carcinoma is classified according to TNM into T1, T2, T3 and T4 stages. The higher the T stage, the worse the prognosis of the patient, as it involves the role of the HIF-1a transcription factor accumulated under hypoxic condition due to inactivation of VHL, thus activating VEGF. So far, clear cell renal cell carcinoma frequently found in smoking males of fifth decade of age or older has not been explained.. An observational analytic study was conducted on the sample of paraffin blocks of patients with clear cell renal cell carcinoma in 2010-2016. T1, T2, T3, and T4 stages of 9 samples, 12 samples, 12 samples and 6 samples, respectively, were collected in Anatomic Pathology Laboratory, Dr. Soetomo Hospital, Surabaya. Detection of HIF-1a and VEGF expression was performed using immunohisto-chemical immunity with HIF-1a and VEGF antibodies. The results were analyzed statistically by Kruskal-Wallis and Mann-Whitney methods. The correlation between HIF-1a and VEGF in T stages was analyzed using Spearman method. There was a difference of HIF-1a expression between stage T1 with T2, T1 with T3, T1 with T4 (p=0.041, p=0.000, and p=0.002), stage T2 with T3 and stage T2 with T4 (p=0.001, and p=0.013). There was a difference in VEGF expression in stage T1 with T2, T1 with T3, T1 with T4 (p=0.007, p=0.000, and p=0.002), and stage T2 with T3 (p=0,001). There was a correlation between HIF-1a and VEGF expressions with all T stages (rs=0.624 with p 0.000). As a conclusion, the higher the stage of T, the higher the expression of HIF-1a and VEGF. The higher the levels of HIF-1a and VEGF, the worse the prognosis of clear cell renal carcinoma. HIF-1a and VEGF play a role in the pathogenesis of clear cell renal cell carcinoma. Thus, HIF-1a and VEGF can be developed as prognostic markers. Increased Hif-1aAnd Vegf Expression Found In Various T Stages Of Clear Cell Renal Cell Carcinoma


2017 ◽  
Vol 14 (3) ◽  
pp. 3065-3070 ◽  
Author(s):  
Fufu Zheng ◽  
Xiaoxu Yuan ◽  
Enjing Chen ◽  
Yunlin Ye ◽  
Xiaofei Li ◽  
...  

BMC Cancer ◽  
2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Marcela García ◽  
Maria Belen Palma ◽  
Jerome Verine ◽  
Santiago Miriuka ◽  
Ana M. Inda ◽  
...  

2020 ◽  
Vol 68 (8) ◽  
pp. 1386-1393
Author(s):  
Milan Radovanovic ◽  
Sasenka Vidicevic ◽  
Jelena Tasic ◽  
Nina Tomonjic ◽  
Zeljka Stanojevic ◽  
...  

We examined the status and role of autophagy, a process of lysosomal recycling of cellular material, in clear cell renal cell carcinoma (ccRCC). Paired samples of tumor and adjacent non-malignant tissue were collected from 20 patients with ccRCC after radical nephrectomy. The mRNA levels of apoptosis (BAD, BAX, BCL2, BCLXL, BIM) and autophagy (ATG4, BECN1, GABARAP, p62, UVRAG) regulators were measured by RT-qPCR. The protein levels of autophagosome-associated LC3-II, autophagy receptor p62, apoptotic marker PARP, as well as phosphorylation of autophagy initiator Unc 51-like kinase 1 (ULK1), its activator AMP-activated protein kinase (AMPK) and 4EBP1, the substrate of ULK1 inhibitor mechanistic target of rapamycin (mTOR), were analyzed by immunoblotting. The mRNA levels of pro-apoptotic BAX, anti-apoptotic BCLXL and pro-autophagic ATG4, p62 and UVRAG were higher in ccRCC tumors. Autophagy induction was confirmed by an increase in phospho-ULK1 and degradation of the autophagic target p62, while apoptotic PARP cleavage was unaltered. AMPK phosphorylation was reduced and 4EBP1 phosphorylation was increased in ccRCC tissue. The expression of apoptosis regulators did not correlate with clinicopathological features of ccRCC. Conversely, high mRNA levels of ATG4, GABARAP and p62 were associated with lower tumor stage, as well as with smaller tumor size and better disease-specific 5-year survival (ATG4 and p62). Accordingly, low p62 protein levels, corresponding to increased autophagic flux, were associated with lower tumor stage, reduced metastasis and improved 5-year survival. These data demonstrate that transcriptional induction of autophagy in ccRCC is accompanied by AMPK/mTOR-independent increase in ULK1 activation and autophagic flux, which might slow tumor progression and metastasis independently of apoptosis.


2014 ◽  
Vol 17 (1) ◽  
pp. 41-49 ◽  
Author(s):  
Z. Q. Xu ◽  
L. Zhang ◽  
B. S. Gao ◽  
Y. G. Wan ◽  
X. H. Zhang ◽  
...  

2007 ◽  
Vol 177 (4S) ◽  
pp. 72-72
Author(s):  
Jean-Jacques Patard ◽  
Nathalie Rioux-Leclercq ◽  
Selim Zerrouki ◽  
Marc Denis ◽  
Patricia Fergelot

Sign in / Sign up

Export Citation Format

Share Document